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Abstract. Autofluorescence spectroscopy shows promising results for
detection and staging of oral (pre-)malignancies. To improve staging
reliability, we develop and compare algorithms for lesion classifica-
tion. Furthermore, we examine the potential for detecting invisible
tissue alterations. Autofluorescence spectra are recorded at six excita-
tion wavelengths from 172 benign, dysplastic, and cancerous lesions
and from 97 healthy volunteers. We apply principal components
analysis (PCA), artificial neural networks, and red/green intensity ra-
tio’s to separate benign from (pre-)malignant lesions, using four nor-
malization techniques. To assess the potential for detecting invisible
tissue alterations, we compare PC scores of healthy mucosa and
surroundings/contralateral positions of lesions. The spectra show large
variations in shape and intensity within each lesion group. Intensities
and PC score distributions demonstrate large overlap between benign
and (pre-)malignant lesions. The receiver-operator characteristic areas
under the curve (ROC-AUCs) for distinguishing cancerous from
healthy tissue are excellent (0.90 to 0.97). However, the ROC-AUCs
are too low for classification of benign versus (pre-)malignant mucosa
for all methods (0.50 to 0.70). Some statistically significant differences
between surrounding/contralateral tissues of benign and healthy tissue
and of (pre-)malignant lesions are observed. We can successfully
separate healthy mucosa from cancers (ROC-AUC.0.9). However,
autofluorescence spectroscopy is not able to distinguish benign from
visible (pre-)malignant lesions using our methods (ROC-AUC
,0.65). The observed significant differences between healthy tissue
and surroundings/contralateral positions of lesions might be useful for
invisible tissue alteration detection. © 2004 Society of Photo-Optical Instrumen-
tation Engineers. [DOI: 10.1117/1.1782611]
Keywords: artificial neural networks; autofluorescence spectroscopy; oral dysplasia;
oral cancer; photodetection; principal components analysis.
Paper 03112 received Sep. 16, 2003; revised manuscript received Jan. 20, 2004;
accepted for publication Feb. 17, 2004.
1 Introduction
Autofluorescence spectroscopy is a noninvasive tool for the
detection of alterations in the structural and chemical compo-
sition of cells, which may indicate the presence of pathologic
tissue.1–4 Autofluorescence of tissues is produced by several
endogenous fluorophores. These include fluorophores from
tissue matrix molecules and intracellular molecules like col-
lagen, elastin, keratin, and NADH. The presence of disease
changes the concentration of these fluorophores as well as the
light scattering and absorption properties of the tissue, due to
changes in a.o. blood concentration, nuclear size distribution,
epithelial thickness, and collagen content. It is therefore ex-
pected that the presence of disease will be identifiably re-
flected in autofluorescence spectral shape and intensity.
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Early detection of premalignant lesions and malignant tu-
mors may reduce patient morbidity and mortality because
treatment at a less invasive stage is more successful, and
therefore is of great clinical importance.5,6 Unfortunately,
~pre-!malignant lesions of the oral mucosa often go by unno-
ticed. In high-risk groups, premalignant and malignant lesions
are often diagnosed in an advanced stage. Once the patient or
dentist does observe a lesion, it is generally unclear whether
the lesion is benign or ~pre-!malignant. Current clinical diag-
nosis procedure therefore includes a biopsy. However, deter-
mining the optimal, i.e., most dysplastic, location for biopsy is
difficult. This leads to repeated biopsies and to the risk of
underdiagnosis, which delays the necessary treatment. Auto-
fluorescence spectroscopy can be a useful tool for guiding the
clinician to the most dysplastic location for biopsy.
Autofluorescence spectroscopy is capable of distinguishing
~pre-!malignant lesions from healthy mucosa in the oral
cavity.7–12 In a previous pilot study for the staging of oral
leukoplakia performed by our group we obtained a sensitivity
of 86% and a specificity of 100% for distinguishing abnormal
from normal tissue. However, the distinction between lesions
in general and healthy oral mucosa is not relevant for the
clinical question of staging visible lesions and finding the op-
timal location for biopsy, since the presence of a lesion is
already established by its being noticed. Therefore, in this
study we investigated the potential of autofluorescence spec-
troscopy for staging oral lesions in a large patient population.
Our primary goal was to separate between benign lesions on
the one hand and dysplastic and malignant lesions on the
other hand, since this is one of the most relevant clinical
questions. For this classification, we applied four different
normalization approaches, including normalization by the
spectrum recorded from the contralateral position of a lesion
in the same patient. This normalization was aimed at correct-
ing for interindividual variations in spectral properties of the
mucosa that are irrelevant for our purpose. However, we can-
not be certain that contralateral tissue in patients is normal.
The influence of carcinogens like tobacco and alcohol can
cause long-term damage of the oral mucosa ~‘‘condemned
mucosa’’!, which can lead to ‘‘field cancerization.’’ 13–16 Fur-
thermore, our pilot study showed that spectroscopic changes
occur not only at the center and border of lesions, but also in
the surroundings, where no abnormalities are visible.17 Also,
Fryen et al.18 found keratinization of the borders of tumors,
enabling imaging detection of even small tumors. These find-
ings suggest that the distinction between healthy and patho-
logic tissue within a patient is not always well defined.17
Therefore, we also applied three normalization methods that
did not use the contralateral position spectrum.
Other studies concerning in vivo autofluorescence spec-
troscopy in the oral cavity have predominantly been aimed at
distinguishing cancerous lesions from healthy tissue, or dis-
tinguishing lesions of any type from healthy tissue.2,8,10,11,19,20
To enable a comparison of the results obtained using our
methods with those achieved in the literature, we therefore
addressed these questions as well.
Besides for lesion classification, autofluorescence of oral
mucosa is also potentially useful for the detection of still in-
visible tissue alterations. However, it is not possible to mea-
sure spectra of invisible lesions to test this hypothesis, since
we clearly cannot know where these lesions are present. To
scan the complete oral cavity using point spectroscopy is, for
practical reasons, not feasible. Therefore, we used another ap-
proach to establish any spectroscopic evidence of lesion de-
velopment. For this purpose, we assume that the process of
lesion transformation can extend to the mucosa at other loca-
tions than the visible lesion. This assumption is again sup-
ported by our pilot study, in which we observed alterations in
the autofluorescence characteristics of tissue surrounding le-
sions, even though the tissue looked healthy to the eye at the
position of measurement.17 We compared autofluorescence
spectra of mucosa surrounding or contralateral to a lesion
with healthy oral mucosa spectra to test for any significant
differences between different data subsets.
2 Materials and Methods
2.1 Volunteer and Patient Population
Autofluorescence spectra were collected from 96 healthy vol-
unteers with no clinically observable lesions of the oral mu-
cosa as described in our previous study, and from 155 patients
with oral lesions after they had given their informed consent.
The population included volunteers from the Department of
Oral and Maxillofacial Surgery of the University Hospital of
Groningen, as well as patients who had been referred to the
same department because of an oral lesion. This study was
approved by the Institutional Review Board of the University
Hospital of Groningen.
2.2 Experiments
Before recording the spectra, volunteers were asked to com-
plete a questionnaire concerning their smoking and drinking
habits, most recently consumed food and beverage, and the
use of any medication. This was done to track the causes of
possible outliers during data analysis. A visual inspection of
the oral cavity was performed by an experienced dental hy-
gienist. In the volunteer group, this was done to ensure that no
oral lesions were present at the time of measurement. In the
patient group, the dental hygienist located and described the
lesions to be measured. If present, the volunteers and patients
were asked to remove their dentures. All patients and volun-
teers rinsed their mouth for 1 min with a 0.9% saline solution
to minimize the influence of consumed food and beverages.
The measurement setup ~Fig. 1!, as described in detail in
our previous paper, consisted of a Xe lamp with monochro-
mator for illumination, a spectrograph and a custom-made set
of 460-nm long-pass and short-pass filters.21 Tissue excitation
wavelengths were 365, 385, 405, 420, 435, and 450 nm
Fig. 1 Experimental setup.
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(bandwidth<15 nm full width at half maximum!. Using dif-
ferent filter sets for different excitation wavelengths would
have extended the emission range, but unfortunately for prac-
tical reasons this was not possible. However, since the emis-
sion spectra of the important tissue fluorophores are very
broad, we expected to collect at least part of the relevant
information.2,22 The measurement probe was disinfected using
2% chlorhexidine digluconate in ethanol and covered with
plastic film. The probe was placed in contact with the oral
mucosa. The measurements were performed in a completely
darkened room to prevent stray light from entering the spec-
trograph. In our patient group, we measured four positions for
each lesion: the center of the lesion, the border, the surround-
ing tissue, and the supposedly healthy tissue at the contralat-
eral position. The dental hygienist performed the measure-
ments.
For each measured location and excitation wavelength,
three sequential measurements of 1-s integration time were
recorded. This enabled us to remove occasional spectra con-
taining extremely high values for discrete pixels due to elec-
tronic noise. On each measurement day, a set of calibration
measurements was performed.
In our previous study, in which we investigated the auto-
fluorescence properties of 13 anatomical locations in the oral
cavity, we concluded that oral mucosa can be divided into
three categories with different spectroscopic characteristics.21
These comprise ~1! the dorsal side of the tongue, ~2! the ver-
milion border of the lip, and ~3! a group of all other anatomi-
cal locations, which are interchangeable with regard to their
autofluorescence characteristics. In this study, we performed
all our data analysis within these three location groups sepa-
rately.
2.3 Data Processing
Data preprocessing was performed as described in our previ-
ous study.21 Preprocessed spectra consisted of 199 data points,
covering the 467- to 867-nm range. For our first approach,
autofluorescence spectra measured at the center of lesions
were divided by spectra recorded from the contralateral posi-
tion. Since the high-wavelength region of spectra shows very
low fluorescence intensity, dividing this part results in ex-
tremely noisy data. For this reason, only the 467- to 801-nm
part of the divided spectra (5160 data points! was consid-
ered.
2.4 Principal Components Scores Multicomparison
Principal components analysis was applied to spectra re-
corded from the center and border positions of lesions, sepa-
rately as well as combined. We compared the values of the
first four principal component ~PC! scores for spectra of le-
sions, divided into benign, dysplastic, and malignant lesions.
This was done to get an impression of the spectral differences
between different lesion types. We performed the nonparamet-
ric Kruskal-Wallis procedure for each excitation wavelength
separately and for four different normalization types. These
comprised normalization by the peak intensity, by the area
under the spectrum, by the spectrum recorded from the con-
tralateral position in the same patient, and nonnormalization.
The Kruskal-Wallis procedure was chosen because of its re-
duced sensitivity to outliers and unbalanced data (5data with
unequal sample sizes for the different groups!. This reduced
sensitivity occurs because the procedure performs an analysis
of variance ~ANOVA! on the ranks of the PC scores, rather
than on their numeric values, as in a standard ANOVA. We
performed a multicomparison on the Kruskal-Wallis results to
test for any significant differences of mean PC scores between
different pairs of lesion types ~benign, dysplastic, malignant!.
If the mean PC scores are not significantly different for dif-
ferent lesion types, classification by means of the information
contained in the PC scores is impossible. Note, however, that
the existence of statistically significant differences alone does
not imply separability of the data classes, since separability
also requires small standard deviations in comparison to the
difference between the mean values.
2.5 Classification of (Pre-)Malignant versus Benign
Lesions
For the purpose of classification of benign versus
~pre-!malignant lesions, we compared autofluorescence spec-
tra recorded from the center of ~pre-!malignant lesions on the
one hand, with center measurements of benign lesions on the
other hand. This was done without normalization, with nor-
malization by the peak intensity, by the area under the spec-
trum, and by the spectrum recorded at the contralateral posi-
tion in the same patient.
For each normalization method, classification was at-
tempted with principal components analysis ~PCA!, artificial
neural networks ~ANNs!, and emission wavelength ratio’s as
have been applied in the literature.4,8,9,12,19,23–29 All methods
were performed on the basis of leave-one-out classification, to
ensure that no overly positive results were obtained. We in-
vestigated all six excitation wavelengths. PCA classification
was applied both with the first 10 and the first four PCs. We
used the combination of PCA and linear classifier, which for
traditional reasons we call the Karhunen-Loeve linear classi-
fier ~KLLC!. This classifier is also known as the regularized
linear classifier assuming normal distributions. Before apply-
ing other classifiers, first the PCA was performed. Then we
applied the quadratic classifier assuming normal distributions
~QNC! to the retrieved first 4 or 10 PCs. An ANN was applied
using one hidden layer consisting of 10 neurons. For the red/
green ratio techniques, we searched for ratios in the literature
that could be applied to our emission wavelength range. We
compared 635/~467 to 489!, 640/500, 680/600, and 630/560
nm ratios.9,25,27,28 To make the methods more robust, we inte-
grated spectral areas of approximately 4 nm width around the
selected emission wavelengths. We calculated receiver opera-
tor characteristics ~ROC! curve areas using leave-one-out
~LOO! classification for all methods. In these curves, sensi-
tivities for detection of lesions are plotted against correspond-
ing values of 1 minus the specificity. The more accurately a
method separates the data classes, the closer the correspond-
ing ROC-AUC ~ROC-area under the curve! approximates 1.
We compared the areas under different ROC curves. This en-
abled us to make a fair judgment of the effectiveness of dif-
ferent methods without being constricted to single values of
sensitivity and specificity, which largely depend on the thresh-
old value chosen.30 Some of the calculations were repeated for
the combined set of center and border measurements to inves-
tigate whether this affected the results.
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2.6 Distinguishing Lesions from Healthy Mucosa
We calculated ROC-curves to distinguish ~1! cancerous le-
sions or ~2! the complete set of lesions on the one hand from
healthy tissue on the other hand. We used the four red/green
ratio techniques as described above and the KLLC on the first
10 PC scores. We compared the center measurements of all
lesions to the healthy oral mucosa data set, leaving out spectra
recorded from the vermilion border of the lip and the dorsal
side of the tongue for both groups. We evaluated areas under
the ROC curve using LOO procedures for all excitation wave-
lengths. We repeated the calculations for border measure-
ments and for the combined center and border measurements
of lesions to see whether extending the dataset could improve
the results.
2.7 Detection of Invisible Tissue Alterations
For assessing the possibility of early lesion detection, we per-
formed a multicomparison on the PC scores of spectra re-
corded from three groups of mucosa: healthy oral mucosa,
tissue surrounding a lesion, and tissue contralateral to a le-
sion. Spectra were normalized by the area under the spectrum.
We compared the means of the first four PC scores for each of
the six excitation wavelength separately to test for any statis-
tically significant differences ~24 comparisons!. This was
done for six different data subsets. Again, we used the non-
parametric Kruskal-Wallis procedure and performed multi-
comparisons on the outcomes. Based on the outcomes of these
tests, we also calculated ROC-AUCs for classification using
the KLLC on the first 10 PC scores.
3 Results
3.1 General Description of the Data
Our volunteer population was already described in our previ-
ous paper and consisted of 97 healthy volunteers21 ~mean age
50, range 18 to 85, standard deviation 16 years!. Our patient
population consisted of 155 persons ~mean age 57, range 20
to 91, standard deviation 13 years!. Some patients suffered
from multiple lesions, so that a total of 172 unique lesions
could be measured. Several lesions were measured two or
three times at different occasions for comparison, leading to a
total of 199 lesion measurements sessions. Lesion character-
istics are described in Table 1.
Of the 199 measurement sessions on lesions, 23 were left
out of the analysis because they could not be staged satisfy-
ingly, could not be located clinically, or had already been
receiving therapy. These sessions were saved as additional test
data.
In 13 of the remaining 176 measurement sessions, the con-
tralateral tissue of the lesions could not be measured for vari-
ous reasons. For example, the lesion was present bilaterally,
the lesion was large and centrally located, or the patient had
abnormalities at the contralateral position that did not allow
classification of the tissue as healthy. For our staging algo-
rithm development approach using divided spectra, we substi-
tuted the spectra measured at the surrounding tissue for these
cases if possible. For 2 of the 176 valid measurement ses-
sions, the ratio spectra were not calculated at all because sur-
rounding and contralateral tissue spectra both could not be
measured, leaving 176 sessions for approach A and 174 ses-
sions for approach B.
The clinical staging of the lesions was based on clinical
appearance in the case of obviously benign and therefore un-
biopsied lesions, and on histology reports in the case of sus-
picious lesions. Of the 176 measurement sessions that were
included in the data analysis, 20 were classified as squamous
cell carcinomas, 1 turned out to be an adenocarcinoma, and 21
were dysplastic lesions ~17 leukoplakia, 2 erythroplakia, 1
erosive leukoplakia, and 1 actinic keratosis!. The remaining
134 lesions were classified as benign lesions.
We performed our analysis in location group 3 only
(5all anatomical locations besides the dorsal side of the
tongue and the vermilion border of the lip!, because the
amount of dysplastic and malignant lesions in the other cat-
egories was too low to enable a reliable analysis. The mea-
surement sessions of lesions at the vermilion border of the lip
and the dorsal side of the tongue were saved as additional test
data for the algorithms.
3.2 Autofluorescence Spectra Characteristics
The median fluorescence spectra for center and border mea-
surements at healthy tissue, benign lesions, dysplastic lesions,
and malignant tumors at excitation wavelength 405 nm are
shown in Fig. 2. We chose to plot median instead of average
spectra, since averaged spectra are more sensitive to outliers
and can therefore be biased. It is clear from Fig. 2~a! that
lesions produce less autofluorescence than healthy tissue.
However, note that the spectra recorded from dysplastic le-
sions are in between those recorded from benign lesions and
from healthy tissue. The normalized plot @Fig. 2~b!# shows
that lesions and especially malignant tumors have relatively
more fluorescence in the red spectral range. Again, note the
mixing of benign and dysplastic lesions.
Figure 3 shows the 405-nm excitation median fluorescence
spectra of center and border measurements of benign, dys-
plastic, and malignant lesions, normalized by spectra mea-
sured at the contralateral position in the same patients. Dys-
plastic and benign lesions again show similar median spectra.
In Fig. 4, we have plotted example spectra recorded from a
benign, a dysplastic, and a malignant lesion to illustrate that
there is no general trend of fluorescence characteristics in re-
lation to lesion type. All lesion types can show porphyrin-like
peaks, not only malignant or dysplastic lesions. This peak is
of the same shape as the one frequently observed in our
healthy volunteer study, especially at the dorsal side of the
tongue.21 For all three lesion types, in most cases, the center
of a lesion shows less fluorescence intensity than the con-
tralateral tissue recorded in the same patient. However, the
percentage of cases in which the center of a lesion produces
less total intensity than the contralateral tissue is only 67% for
benign, 55% for dysplastic, and 72% for cancerous lesions,
showing that this criterion is not useful for classification.
3.3 Statistical Results
3.3.1 Principal components scores multicomparison
Plots of the first four PCs for all center and border of lesions
spectra after normalization by the area under the spectra are
shown in Fig. 5 ~405-nm excitation!. Note that PC1 appears to
correspond to the bulk autofluorescence, PC2 contains the
Clinical study for classification . . .
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porphyrin-like peak around 638 nm, while PC3 and PC4 con-
tain a mixture of blood absorption and porphyrin-like fluores-
cence. The first four PCs accounted for .99% of the variance
in the data.
We observed that the differences between tumors and be-
nign lesions, as well as between tumors and dysplastic le-
sions, were more prominent than those between dysplastic
and benign lesions ~i.e., a higher percentage of the 24 PC
Table 1 Summary of lesions included in the dataset; all dysplasias and cancerous lesions were histologically proven.
Lesion Type
Number of Lesions (Number of
Measurement Sessions)
Included in the Analysis,
Location Group 3
(Number of Sessions)
Suspicious Lesions, Included in the
Analysis, Location Group 3
(Number of Sessions)
Squamous cell carcinoma Malignant: 19 (20) Malignant: 16 (16) Malignant: 16 (16)
Adenocarcinoma Malignant: 1 (1) Malignant: 1 (1) Malignant: 0 (0)
Erythroplakia Dysplastic: 2 (2) Dysplastic: 2 (2) Dysplastic: 2 (2)
Leukoplakia Dysplastic: 13 (17) Dysplastic: 9 (13) Dysplastic: 9 (13)
Benign: 50 (56) Benign: 45 (51) Benign: 45 (51)
Erosive leukoplakia Dysplastic: 1 (1) Dysplastic: 1 (1) Dysplastic: 1 (1)
Benign: 1 (1) Benign: 1 (1) Benign: 1 (1)
Actinic keratosis Dysplastic: 1 (1) Dysplastic: 0 (0) Dysplastic: 0 (0)
Benign: 5 (7) Benign: 0 (0) Benign: 0 (0)
Oral lichen planus Benign: 35 (39) Benign: 33 (37) Benign: 32 (36)
Candidiasis Benign: 12 (15) Benign: 10 (13) Benign: 10 (13)
(Nonspecific) ulcus Benign: 9 (10) Benign: 7 (8) Benign: 6 (7)
Lymphangioma Benign: 1 (1) Benign: 1 (1) Benign: 0 (0)
Fibroma Benign: 4 (4) Benign: 3 (3) Benign: 0 (0)
Aphtous lesion Benign: 1 (1) Benign: 1 (1) Benign: 0 (0)
Mucosa morsicatio Benign: 1 (1) Benign: 0 (0) Benign: 0 (0)
Actinomycosis Benign: 1 (1) Benign: 1 (1) Benign: 1 (1)
Scar tissue Benign: 2 (2) Benign: 1 (1) Benign: 1 (1)
After CO2 laser treatment Benign: 3 (9) Benign: 0 (0) Benign: 0 (0)
Lingua geographica Benign: 1 (1) Benign: 1 (1) Benign: 0 (0)
Hyperemic mucosa Benign: 1 (1) Benign: 1 (1) Benign: 0 (0)
Smoker’s palate Benign: 1 (1) Benign: 1 (1) Benign: 0 (0)
Heavy deposit of the tongue Benign: 1 (1) Benign: 0 (0) Benign: 0 (0)
Mucoce`le Benign: 2 (2) Benign: 0 (0) Benign: 0 (0)
Paresthesia of the tongue Benign: 1 (2) Benign: 0 (0) Benign: 0 (0)
Rest lesion mucoepidermoid carcinoma Unknown: 1 (1) Unknown: 0 (0) Benign: 0 (0)
Total Malignant: 20 (21) Malignant: 17 (17) Malignant: 16 (16)
Dysplastic: 17 (21) Dysplastic: 12 (16) Dysplastic: 12 (16)
Benign: 132 (156) Benign: 106 (120) Benign: 96 (110)
Unknown: 1 (1)
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scores comparisons yielded significant differences, Table 2!.
The results look similar for all excitation wavelengths consid-
ered, however, 365-nm excitation tends to yield somewhat
more differences between lesion groups. The normalization
method that exposed the most differences was normalization
by the area under the curve.
The diversity in the group of benign lesions can possibly
reduce the amount of significant differences that are found
between benign and ~pre-!malignant lesions by creating more
spectral variation. We therefore selected only those benign
lesions that were clinically suspicious for dysplasia and/or
malignancy ~leukoplakia, lichen planus, candida, ulcus, eryth-
roplakia, and actinic keratosis! and applied PCA for the clas-
sification of dysplastic and malignant versus benign lesions
again. This approach did not improve the results. The results
must be interpreted carefully, because reduction of the data set
on itself makes the appearance of statistically significant dif-
ference less probable.
3.3.2 Classification of (pre-)malignant versus benign
lesions
In general, an area under the ROC curve close to 0.5 indicates
that the method used has failed and is as effective as random
classification. An area .0.9 indicates excellent classification,
corresponding to excellent separability of the two classes. The
results for ANN, PCA, KLLC, and QNC for distinguishing
~pre-!malignant from benign lesions all turned out to be bad
(area,0.65). Including the spectra recorded at the borders of
lesions did not improve the results, nor did the use of border
spectra exclusively. Selecting only those benign lesions that
were clinically suspicious for dysplasia or SCC, as described
before, still gave areas under the ROC,0.65. Distinguishing
between benign and dysplastic lesions was not successful ei-
ther (areas,0.65). We applied the KLLC classifier on the
first 10 PCs for spectra that had been divided by spectra re-
corded from the contralateral position. This resulted in ROC
curve areas of approximately 0.5 for all excitation wave-
lengths, meaning that classification of dysplastic versus be-
nign lesions failed. For the distinction between benign and
malignant lesions, i.e., excluding dysplastic lesions from the
analysis, areas were higher ~0.59 to 0.75!. This implies, in
agreement with the PC scores multicomparison results, that
the difficulties are caused by the problems in distinguishing
dysplastic from benign lesions and not so much by distin-
guishing benign from cancerous lesions. In fact, the distinc-
tion between dysplastic and malignant lesions could more
successfully be made than that between benign and dysplastic
lesions ~areas under the ROC curve 0.67 to 0.82 for KLLC on
the first 10 PCs, depending on the excitation wavelength!.
3.3.3 Distinguishing lesions from healthy tissue
The results for distinguishing all lesions or cancerous lesions
only from healthy oral tissue are shown in Table 3. Classifi-
Fig. 2 (a) Median autofluorescence spectra of lesions of the oral mucosa of different types, excitation wavelength 405 nm and (b) normalized
spectra.
Fig. 3 Median autofluorescence spectra of different lesion types in the
oral cavity, excitation wavelength 405 nm, divided by spectra re-
corded from the contralateral position in the same patient.
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cation was most successful for distinguishing cancerous from
healthy tissue ~ROC-AUC: mean 0.9360.03 for all excitation
wavelengths and methods, except ANN!. The maximum value
of ROC-AUC was 0.97, occurring for ratios 1 and 2 and the
combined ratios for several excitation wavelengths between
405 and 435 nm. The ROC-AUC for the separation of com-
bined lesions ~suspicious benign, dysplastic, and malignant!
from healthy oral mucosa was lower than for the separation of
cancerous lesions from healthy mucosa, but still was high
~mean value1standard deviation ROC-AUC: 0.8160.03 for
all excitation wavelengths and methods, except ANN!. The
maximum ROC-AUC was 0.88 at 365 nm excitation using
KLLC on PC scores. The addition of measurements recorded
from the border of the lesion did not improve the results, nor
did the use of border spectra exclusively. This suggests that
autofluorescence characteristics recorded from the center of
lesions contain the most information about tissue type. This
contradicts the results of our pilot study, in which the border
of lesions seemed to contain the most information. However,
this study is based on a larger patient population and therefore
more reliable.
3.3.4 Detection of invisible tissue alterations
Multicomparison of the first four PC scores for the surround-
ings and contralateral sites of benign, dysplastic, and malig-
nant lesions showed some significant differences in mean val-
ues for different PC scores. These results are not shown in a
table. For benign versus malignant lesions, 54% of the 24 PC
scores ~six excitation wavelengths, four PCs! were signifi-
cantly different. For dysplastic versus malignant lesions, this
number was reduced to 25%, and for benign versus dysplastic
lesions only 4% of PC scores were significantly different. A
multicomparison of spectra with randomly attached labels of
benign, dysplastic, and malignant returned no statistically sig-
nificant differences at all. This makes us confident that the
calculated significant differences for PC scores between dif-
ferent lesion types are not a statistical artifact but truly are the
consequence of different spectroscopic properties. However,
Fig. 4 Spectra of different lesion types in different patients at an exci-
tation wavelength of 405 nm of (a) leukoplakia of the retromolar
trigone (benign), (b) leukoplakia at the transition of tongue to floor of
mouth (dysplastic), and (c) planocellular carcinoma of the mandibular
fold (malignant).
Fig. 5 First four PC loadings of spectra of center and border measure-
ments of lesions that were included in the analysis with an excitation
wavelength of 405 nm. Loadings are normalized to the area under the
curve and centered around zero.
de Veld et al.
946 Journal of Biomedical Optics d September/October 2004 d Vol. 9 No. 5
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 1/8/2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
the causes of these differences remain speculative because
biopsy-proven histologic data were not available from these
apparently healthy locations.
To further investigate the differences, we repeated the cal-
culations for spectra recorded either at the surroundings of
lesions or at the contralateral position, separately. For sur-
rounding positions, no differences for the three lesion types
were observed at all. For the contralateral measurements, we
found 46% differences between benign and malignant and
29% between dysplastic and malignant lesions. This suggests
that, to our surprise, contralateral tissue is more influenced by
lesion type than surrounding tissue is. Possibly, the observed
differences in PC scores are caused by field cancerization or
tobacco smoking habits, which are correlated to lesion type.
The tissue surrounding lesions might demonstrate some
lesion-related effects, like slight inflammation, that over-
shadow the effects of field cancerization and smoking habits.
This might explain why benign and ~pre-!malignant lesions
show more differences within the contralateral than within the
surrounding data subset. A PC scores multicomparison be-
tween surroundings and contralateral spectra of lesions ~all
types grouped or separately!, showed no significant differ-
ences between these locations. However, this still does not
rule out the possibility of lesion-related effects overshadowing
the differences caused by field cancerization. The standard
deviations of PC scores within lesion type groups can be
larger than a possible difference between surroundings and
contralateral tissues. For our sample size, this would make it
improbable to detect significant differences even if they exist
in the general population.









Nonnormalized 38 38 8 28
Normalized by the peak intensity 29 33 8 23
Normalized by the area under the spectrum 67 54 4 42
Normalized by the spectrum recorded at the contralateral
position
13 0 0 4
For each comparison between two lesion types, 24 pairs of PC scores were available (first four PC scores, six excitation wavelengths). Comparisons were performed
using the Kruskal-Wallis procedure. Benign and malignant lesions show the most differences, hardly any differences exist between benign and dysplastic lesions.
Table 3 Areas under the ROC curve.
10 PCs Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 114 Ratios Combined ANN on 10 PCs
Squamous cell carcinoma versus healthy oral mucosa, center measurements
365 nm 0.92 0.93 0.93 0.82 0.88 0.88 0.88 0.58
385 nm 0.92 0.94 0.95 0.90 0.92 0.92 0.95 0.44
405 nm 0.92 0.96 0.97 0.95 0.95 0.95 0.97 0.50
420 nm 0.92 0.97 0.96 0.94 0.91 0.93 0.96 0.47
435 nm 0.93 0.95 0.97 0.93 0.93 0.93 0.97 0.60
450 nm 0.94 0.95 0.91 0.89 0.89 0.91 0.91 0.68
Center measurements of tumors, dysplastic, and suspicious benign lesions versus healthy oral mucosa
365 nm 0.88 0.84 0.78 0.73 0.80 0.80 0.80 0.51
385 nm 0.85 0.83 0.82 0.77 0.82 0.83 0.82 0.50
405 nm 0.83 0.81 0.82 0.79 0.81 0.81 0.81 0.50
420 nm 0.83 0.81 0.81 0.79 0.81 0.81 0.81 0.51
435 nm 0.84 0.81 0.81 0.79 0.81 0.82 0.82 0.49
450 nm 0.84 0.83 0.76 0.77 0.81 0.82 0.81 0.51
All spectra were recorded within location group 3. Areas were calculated using LOO analysis for the KLLC. Ratio 1: 680/600 nm; ratio 2, 635/(455 to 490) nm; ratio
3, 630/560 nm; ratio 4, 500/640 nm. An ANN using 10 hidden neurons. Only ‘‘real’’ lesions located in anatomical location group 3 were included. We applied
normalization by the area under the spectrum.
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To further investigate the underlying causes for the ob-
served significant differences, we expanded the PC scores
analysis data set with spectra from the healthy volunteer ref-
erence database. Spectra recorded from the dorsal side of
tongue and at the vermilion border of the lip again were ex-
cluded. Note that the expansion of the data set leads to the
extraction of different principal components loadings. These
are now mainly determined by the—much larger—set of
healthy mucosa spectra.
The results are summarized in Table 4. The combination of
healthy reference database spectra with spectra recorded from
the surroundings and contralateral position of lesions, yields
more significant differences in PC scores between the subsets.
This is probably caused by the larger amount of data avail-
able, which makes the appearance of any differences that exist
in the general population more probable. Again, differences
are more prominent in the subset containing contralateral
measurements than in the subset with spectra recorded from
the surroundings of lesions. This might be explained by the
spectral effects of field cancerization or smoking habits, as
explained before.
After obtaining these results, we were curious about the
possibility to classify lesions by means of autofluorescence
spectra recorded at the surroundings and contralateral posi-
tion. We therefore applied the linear classifier using 10 PCs to
separate ~pre-!malignant from benign lesions. Areas under the
ROC curves were between 0.50 and 0.72 for the combined
set, meaning that classification was useless. Distinguishing
malignant from benign lesions gave comparable results. The
distinction between malignant and dysplastic lesions could
more successfully be made ~surroundings, 0.52 to 0.67; con-
tralateral, 0.67 to 0.85; combined, 0.65 to 0.75!. Again, the
contralateral data set performed best. We added the healthy
oral mucosa reference database and attempted classification of
benign and healthy oral mucosa versus dysplastic and malig-
nant mucosa. ROC-AUCs were 0.62 to 0.82, best results were
obtained for the contralateral dataset. Distinguishing all le-
sions from healthy mucosa by means of their surrounding
and/or contralaterally recorded spectra resulted in ROC-AUCs
of 0.59 to 0.73. We can conclude that classification of lesion
type by means of surrounding and contralateral tissue spectra
was not possible. However, the results imply that some infor-
mation on tissue type is contained at the clinically healthy
contralateral tissue.
4 Discussion
We were well able to distinguish lesions in general from
healthy tissue ~maximum ROC-AUC50.88 using KLLC and
PCA! and achieved excellent results in distinguishing cancer-
ous tumors from healthy tissue ~maximum ROC-AUC50.97
using ratios!. The results were not influenced noticeably by
the choice of excitation wavelength. Concatenation of spectra
recorded at different excitation wavelengths, as has been sug-
gested in the literature, did not improve the results.10 The best
results were obtained when spectra were normalized by the
AUC. Center measurements contained the most relevant in-
formation. Normalization by the spectrum recorded at the
contralateral position revealed the fewest significant differ-
ences between lesion types. To our surprise, this contradicts
the results found in our pilot study by Van Staveren et al.17
Our results for distinguishing lesions from healthy oral
mucosa, as well as for distinguishing cancer from healthy
mucosa, were comparable with results found in the literature.
Majumder et al.11 achieved 86% sensitivity, 63% specificity
for distinguishing oral cancer from healthy mucosa, while
Wang et al.12 achieved a sensitivity of 81% and a specificity
of 94% for the same problem. Gillenwater et al.9 established a
94% sensitivity, 100% specificity for distinguishing abnormal
from normal oral mucosa, while Mu¨ller et al.20 found a 96%
sensitivity, 96% specificity for the same question when using
a combination of autofluorescence and diffuse reflectance
measurements.
Contrary to our success in distinguishing all lesions or can-
cerous lesions from healthy oral mucosa, the relevant clinical
question could not be answered. We were not able to separate
benign from ~pre-!malignant lesions using our methods ~area
under the ROC curve ,0.65 for all methods!. In our opinion,
this is due largely to the fact that the oral cavity is more
complex than other organs, in which autofluorescence spec-
troscopy for the staging of lesions has been applied more
successfully using comparable excitation
Table 4 Percentage of significantly different PC scores between pairs of different lesion types, data including healthy volunteer measurements.
Pair of Tissue Types Compared







Benign versus malignant 0 29 54
Dysplastic versus malignant 0 17 21
Benign versus dysplastic 4 0 8
Healthy versus benign 33 21 50
Healthy versus dysplastic 8 0 25
Healthy versus malignant 42 50 58
For each comparison between two lesion types, 24 pairs of PC scores were available (first four PC scores, six excitation wavelengths). Comparisons were performed
using the Kruskal-Wallis procedure. We applied normalization by the area under the spectrum.
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wavelengths.2,25,31–34 The reasons for this complexity can be
as follows. In general, tumors as well as benign and dysplastic
lesions can be of various degrees of keratinization, hyperpla-
sia, and blood content. All these factors influence the shape
and intensity of autofluorescence spectra, and since they show
large variance within each lesion category, a mixing of cat-
egories by means of autofluorescence spectroscopy classifica-
tion can easily result. In the oral cavity, there could be more
difficulties than in other organs, because the different oral
tissue types may show different reactions to disease. How-
ever, we would need large numbers of lesions for each ana-
tomical location to test this hypothesis. The mixing of differ-
ent lesion types for our dataset can be observed in Fig. 2, in
which median spectra from benign and dysplastic lesions are
intertwined for normalized as well as for nonnormalized au-
tofluorescence spectra.
In contrast with our findings, Wang et al. established a
sensitivity of 81% and a specificity of 96% for distinguishing
‘‘premalignant and malignant’’ lesions from ‘‘benign’’ lesions
in the oral cavity by means of autofluorescence
spectroscopy.35 Spectra were recorded under 330-nm excita-
tion and classified using a partial least-squares and artificial
neural network ~PLS-ANN! classification algorithm. The di-
vergence of our mutual results can potentially be explained by
the choice of excitation wavelength, since a lower excitation
wavelength may lead to excitation of different fluorophores.
However, we expect to collect at least part of the fluorescence
from the important tissue fluorophores as well, since they
show broad absorption and emission spectra. The use of dif-
ferent multivariate analytic methods is probably not the cause
for the divergence in results either, since we applied many
different methods, which did not improve the results. Also,
the methods used are quite similar in concept. We therefore
think that the discrepancy in results is probably caused by the
different patient populations. All lesions measured by Wang
et al. were located at the oral buccal mucosa, and all were
induced by areca quid chewing and smoking habits. Their
lesion set thus was much more homogeneous, which may fa-
cilitate the classification.
In contrast with our results as well, Heintzelman et al.
achieved 90% sensitivity and 88% specificity for distinguish-
ing dysplastic and cancerous tissue from benign and healthy
oral mucosa in a training set, and 100% sensitivity with 98%
specificity in their validation set using three excitation
wavelengths.10 These results cannot be compared to ours be-
cause a different classification was performed. If the number
of benign lesions is relatively low, effectively the more suc-
cessful lesion/healthy classification has been made. The re-
sults for the training set for this question are comparable to
ours. Sensitivity and specificity for the validation set are
higher than we found, which might be explained by the data
distribution ~277 normal sites, 2 dysplastic, and 2 cancerous
sites! or the combination of excitation wavelengths used.
Diagnostic algorithms based on the presence of a
porphyrin-like peak around the 638-nm emission wavelength
have been applied successfully in the literature.9,36 It seems
generally accepted that this peak is caused by endogenous
porphyrin production. This may be either by cells of the body,
or by microorganisms. In our previous study, we have shown
that rubbing the tongue could diminish the height of the
porphyrin-like peak by 30 to 40%, suggesting that at least part
of the porphyrins are located outside of the tissue. We have
not tried to diminish porphyrin-like peaks by rubbing lesions
because of practical drawbacks.
In our study we saw porphyrin-like peaks appearing in
benign lesions ~32%!, dysplastic lesions ~19%!, malignant le-
sions ~73%!, and even occasionally in healthy oral mucosa.21
Therefore, ratio 2 @5635/(455 to 490) nm# was not success-
ful in distinguishing benign lesions from dysplastic and ma-
lignant lesions in our patient population. The high occurrence
rate of 638-nm fluorescence of tumors in combination with
the reduced total fluorescence intensity explain why the less
relevant distinction between malignant and healthy tissue
could successfully be made using ratio 2.
We observed statistically significant differences between
PC scores of surrounding and contralateral mucosa of benign
lesions, on the one hand, and of dysplastic and malignant
lesions, on the other hand. This is surprising, because the
differences between center and border measurements of le-
sions of both groups were not even pronounced enough to
allow for a reliable classification. However, we must remem-
ber that statistically significant differences between means of
groups do not imply separability of the classes. Furthermore,
it is possible that the differences found for surrounding and
contralateral tissues are not a result of an invisible effect of
the lesion itself, but merely a symptom of field cancerization.
In fact, this is very probable when considering the fact that
contralateral tissue showed more significant differences be-
tween benign, dysplastic, and malignant lesions than sur-
rounding tissue did. However, all conclusions remain specu-
lative because biopsy-proven histologic data of the
surroundings and contralateral positions were not available.
Applying autofluorescence imaging may expand our knowl-
edge of this subject, and may be useful—if not for lesion
staging, then still for lesion detection. This is especially help-
ful for follow-up inspection in patients at high risk for devel-
oping oral cancer.
To potentially improve our diagnostic accuracy for lesion
staging, we will include diffuse reflectance spectra in our fu-
ture analysis. These spectra are sensitive to scattering and
absorption properties of the tissue, and therefore indirectly to
the degree of keratinization and the amount of blood, respec-
tively. Incorporating reflectance spectra into the classification
algorithms may reduce the influence of variations in blood
content and keratinization and thus the amount of information
that is nonspecific for malignant transformation. Performance
can possibly be improved by including other optical diagnos-
tical methods.
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